The Epithelial Sodium Channel Is a Modifier of the Long-Term Nonprogressive Phenotype Associated with F508del CFTR Mutations-Reference-Cited by-同舟云学术

The Epithelial Sodium Channel Is a Modifier of the Long-Term Nonprogressive Phenotype Associated with F508del CFTR Mutations

Published:2017-12 Issue:6 Volume:57 Page:711-720
ISSN:1044-1549
Container-title:American Journal of Respiratory Cell and Molecular Biology
language:en
Short-container-title:Am J Respir Cell Mol Biol

Author:

Agrawal Pankaj B.¹²³,Wang Ruobing⁴,Li Hongmei Lisa⁵⁶⁷,Schmitz-Abe Klaus²³,Simone-Roach Chantelle⁴,Chen Jingxin⁸,Shi Jiahai⁹,Louie Tin¹⁰,Sheng Shaohu⁸,Towne Meghan C.²³,Brainson Christine F.¹¹,Matthay Michael A.¹²¹³,Kim Carla F.⁴⁵⁶⁷,Bamshad Michael¹⁴,Emond Mary J.¹⁰,Gerard Norma P.⁴¹⁵,Kleyman Thomas R.⁸¹⁶,Gerard Craig⁴

Affiliation:

1. Divisions of Newborn Medicine

2. Genetics and Genomics

3. Gene Discovery Core, Manton Center for Orphan Disease Research

4. Pulmonary and Respiratory Diseases, and

5. Stem Cell Program, Division of Hematology/Oncology, Boston Children’s Hospital, Boston, Massachusetts

6. Harvard Stem Cell Institute, Cambridge, Massachusetts

7. Department of Genetics, and

8. Departments of Medicine

9. Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong SAR

10. Biostatistics and Center for Biomedical Statistics

11. Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky; and

12. Departments of Medicine and

13. Anesthesia, Cardiovascular Research Institute, University of California–San Francisco, San Francisco, California

14. Pediatrics and Genome Sciences, University of Washington, Seattle, Washington

15. Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

16. Cell Biology, and Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania

Publisher

American Thoracic Society

Subject

Cell Biology,Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Link

http://www.atsjournals.org/doi/pdf/10.1165/rcmb.2017-0166OC

Reference66 articles.

1. Diagnostic Sweat Testing: The Cystic Fibrosis Foundation Guidelines

2. Airway Surface Dehydration in Cystic Fibrosis: Pathogenesis and Therapy

3. Origins of Cystic Fibrosis Lung Disease

4. Cystic fibrosis transmembrane conductance regulator and the etiology and pathogenesis of cystic fibrosis

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Solute Carrier Family 26 Member 9 Is a Modifier of the Rapidly Progressing Cystic Fibrosis Associated with F508del CFTR Mutations;2024-01-04

2. Furin as a therapeutic target in cystic fibrosis airways disease;European Respiratory Review;2023-05-03

3. Preclinical evaluation of the epithelial sodium channel inhibitor AZD5634 and implications on human translation;American Journal of Physiology-Lung Cellular and Molecular Physiology;2022-11-01

4. A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease;Cell Chemical Biology;2022-06

5. Downregulation of epithelial sodium channel (ENaC) activity in cystic fibrosis cells by epigenetic targeting;Cellular and Molecular Life Sciences;2022-04-25